
The Relationship of Industry Payments to Prescribing Behavior: A Study of Degarelix and Denosumab
Keywords: نئوپلاسم پروستات; prostatic neoplasms; drug prescriptions; practice patterns; physicians'; Medicare Part B; reimbursement mechanisms; CMS; Centers for Medicare and Medicaid Services; FDA; United States Food and Drug Administration;